Dr Petrou S. Athanasios is a Consultant Surgeon specialized in Hepatobiliary, Pancreatic (HPB) and Surgical Oncology. He completed his Higher Surgical Training in the First Department of Surgery, University of Athens Medical School, LAIKO Teaching Hospital, Athens, Greece in 2009. At the period of his special training he has also worked as Honorary Clinical Fellow in HPB Surgery at the Department of HPB Surgery, Hammersmith Hospital, London, UK. During his Higher Surgical Training, he trained extensively in HPB Surgery along with Surgical Oncology.
His expertise in HPB and Surgical Oncology was further enhanced during his Fellowships in The Royal Marsden Hospital NHS Trust – Department of Academic Surgery (HPB & Surgical Oncology), and, in the Churchill Hospital, University of Oxford – HPB & Transplant Centre (Upper GI/HPB, and, Transplant surgery). He gained a Master of Science (MSc in Hepato-Pacreatico-Biliary/HPB Surgery), in 2009 from the Democritus University of Thrace Medical School, and a PhD in Medicine (Liver Surgery), in 2010 from the National and Kapodestrian University of Athens, Medical School.
Dr Petrou deals with Surgical Treatments and Management for the whole spectrum of HPB diseases. These includes gallstone, biliary and pancreatic diseases. Surgery for cancer of the liver, biliary system and the pancreas also fall within his expertise. He also has a special interest in Surgical Oncology. The treatment of the Upper Gastrointestinal Tract malignancies (Oesophageal & Gastric Cancer), as well as, the Abdominal Retroperitoneal Sarcomas, Colorectal Surgery, and, the Adrenal surgery are integrated in his proficiency. He is formally trained in minimal invasive surgery (Laparoscopic and Robotic surgery), and, he recently established and he is the Head of the program of the Advanced Laparoscopic HPB Surgery at the American Medical Center, CY, EU.
The main topic of his clinical and research interest is the treatment of non-resectable Pancreatic and Liver malignancies with the IRE – Irreversible Electroporation method (Nanoknife). Since 2014 he is leading the Nanoknife Program for the treatment of unresectable Liver and Pancreatic tumors, at the American Medical Center, Nicosia, CY (www.amc.com.cy) Dr Petrou is the Clinical Lead for the HIPEC surgical programs, at the American Medical Center.
In 2017,the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) (http://www.eahpba.org/) assigned him as Member of Committee on Educational Activities. Dr Petrou is a member of the Association of Upper GI Surgeons and the Association of Surgeons of Great Britain and Ireland. He is also Member of the International Hepato – Pancreato – Billiary Association (IHPBA), of the European Hepato – Pancreato – Billiary Association (EHPBA), and, the European Society of Surgical Oncology (ESSO).
He has more than 100 publications (https://athanasiospetrou.academia.edu/) (scientific original papers and abstracts) in international peer reviewed journals and decades of studies presented in international surgical meetings and conferences.